About Saraca
Saraca was a Healthcare company based in Mardi (India). It manufactures Active Pharmaceutical Ingredients and Intermediates for export. It operates on a B2B model. The company has 409 employees. Its Indian entity Saraca Laboratories Limited reported revenue of ₹310 Cr. The company is recorded as dissolved. Saraca offers products and services including Active Pharmaceutical Ingredients, Intermediates, and By-Products. Its focus areas include Life Sciences, Pharmaceutical Manufacturing, Active Pharmaceutical Ingredients and Drug Intermediates. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Saraca Laboratories Limited, based in Hyderabad, India, produces and markets Active Pharmaceutical Ingredients and Intermediates. Established in 1992, it develops cost-effective processes through RD facilities and exports to over 40 countries. The company focuses on quality, holds certifications like WHO-GMP and USFDA, and employs experienced scientists for consistent production.
- Headquarters Mardi, India
- Employees 409
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website saraca.com
- Legal Name Saraca Laboratories Limited
- Date of Incorporation 11 Jan, 1988
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹310 Cr
FY 2025 · +11% YoY
- Net Profit₹14.58 Cr
FY 2025 · 5% margin
- EBITDA₹25.45 Cr
FY 2025 · 8% margin
- Employee Count409
Associated legal entities of Saraca
Saraca operates through Saraca Laboratories Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Saraca Laboratories Limited CIN U85195TG1988PLC008172 | Active | 11 Jan 1988 | Hyderabad, Telangana | ₹310 Cr | 409 | 10 | View details |
Products & Services of Saraca
Saraca offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients, Intermediates, and By-Products.
Manufactures APIs like Ranitidine HCl for global medical applications.
Produces compounds such as NMSM for pharmaceutical manufacturing.
Offers by-products derived from API production processes.
Board of directors of Saraca Laboratories Limited (Saraca)
Saraca Laboratories Limited is the primary company behind Saraca. The board of Saraca Laboratories Limited currently have 9 directors; the longest-serving is Lingareddy Subba Reddy Venkata, appointed in 1992. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Lingareddy Subba Reddy Venkata DIN 00135847 | Whole-time director | 03 Mar 1992 | 34 yrs 7 mo | Saraca Laboratories Limited |
| Puthana Reddy Subramanyam DIN 00268514 | Managing Director | 16 Dec 1994 | 31 yrs 10 mo | Saraca Laboratories Limited |
| Sree Phani Kumar Reddy Mallidi DIN 00307899 | Director | 09 May 1997 | 29 yrs 5 mo | Saraca Laboratories Limited |
| Venkata Sunil Lingareddy DIN 00268393 | Director | 06 Apr 2000 | 26 yrs 6 mo | Saraca Laboratories Limited |
| Mundla Maha Vishnu DIN 02470664 | Director | 17 Feb 2006 | 20 yrs 8 mo | Saraca Laboratories Limited |
| Prasanth Nandigala DIN 01740471 | Director | 04 Nov 2014 | 11 yrs 11 mo | Saraca Laboratories Limited |
| Hemanth Nandigala DIN 01561731 | Director | 04 Nov 2014 | 11 yrs 11 mo | Saraca Laboratories Limited |
| Gargi Pammi DIN 01744011 | Director | 29 Sep 2017 | 9 yrs | Saraca Laboratories Limited |
| Shailesh Shivappa Biradar DIN 08721019 | Company Secretary | 11 Jun 2019 | 7 yrs 4 mo | Saraca Laboratories Limited |
Financials of Saraca
Figures of Saraca Laboratories Limited, the primary company behind Saraca, for FY 2025. Revenue was ₹310 Cr (+11% year on year). Net profit was ₹14.58 Cr (5% margin). EBITDA was ₹25.45 Cr (8% margin). Revenue has grown at a compounded annual rate of 0% over three years and -2% over five years.
- ₹310 CrRevenue · FY 2025 · +11% YoY
- ₹14.58 CrNet profit · 5% margin
- ₹25.45 CrEBITDA · 8% margin
- ₹8.00 CrPaid-up capital
- 409Employees (provident fund records)
- 0%Revenue CAGR, 3 years
- -2%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Saraca Laboratories Limited are on its company page.
Detailed financial statements for Saraca
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Saraca
Saraca has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Saraca
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Saraca
Saraca is headquartered in Mardi, India. It is registered at Mardi, Himachal Pradesh, India.
Saraca has 409 employees.
The primary company behind Saraca, Saraca Laboratories Limited, reported revenue of ₹310 Cr for FY 2025, up 11% year on year.
Saraca Laboratories Limited, based in Hyderabad, India, produces and markets Active Pharmaceutical Ingredients and Intermediates. Established in 1992, it develops cost-effective processes through RD facilities and exports to over 40 countries. The company focuses on quality, holds certifications like WHO-GMP and USFDA, and employs experienced scientists for consistent production.
Saraca's top competitors include Laurus Labs, Symbiotec and SeQuent.
Saraca offers Active Pharmaceutical Ingredients, Intermediates, and By-Products.
Saraca operates through Saraca Laboratories Limited.
The legal entities of Saraca currently have 9 directors, including Sree Phani Kumar Reddy Mallidi, Shailesh Shivappa Biradar, Puthana Reddy Subramanyam and others.